![Christine Guillen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Christine Guillen is the founder and currently serves as the Chief Executive Officer & Director of ElsaLys Biotech SAS, a company she founded in 2013.
Prior to founding ElsaLys Biotech SAS, she held the position of Director-Project Management at EUSA Pharma SAS from 2005 to 2007 and Head-External Programs at Transgene SA from 2007 to 2013.
Eerdere bekende functies van Christine Guillen
| Bedrijven | Functie | Einde |
|---|---|---|
| ELSALYS BIOTECH | Oprichter | - |
| TRANSGENE | Corporate Officer/Principal | 01-01-2013 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Corporate Officer/Principal | 01-10-2007 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
